280 related articles for article (PubMed ID: 24731928)
41. Performance comparison of deep sequencing platforms for detecting HIV-1 variants in the pol gene.
Nicot F; Jeanne N; Raymond S; Delfour O; Carcenac R; Lefebvre C; Sauné K; Delobel P; Izopet J
J Med Virol; 2018 Sep; 90(9):1486-1492. PubMed ID: 29750364
[TBL] [Abstract][Full Text] [Related]
42. Ultra-Deep Sequencing Analysis on HIV Drug-Resistance-Associated Mutations Among HIV-Infected Individuals: First Report from the Philippines.
SahBandar IN; Samonte G; Telan E; Siripong N; Belcaid M; Schanzenbach D; Leano S; Chagan-Yasutan H; Hattori T; Shikuma CM; Ndhlovu LC
AIDS Res Hum Retroviruses; 2017 Nov; 33(11):1099-1106. PubMed ID: 28569550
[TBL] [Abstract][Full Text] [Related]
43. Human immunodeficiency virus type 1 drug resistance testing: a comparison of three sequence-based methods.
Erali M; Page S; Reimer LG; Hillyard DR
J Clin Microbiol; 2001 Jun; 39(6):2157-65. PubMed ID: 11376051
[TBL] [Abstract][Full Text] [Related]
44. Analysis of discrepancies in the interpretation of antiretroviral drug resistance results in HIV-1 infected patients of Basque Country, Spain.
Muñoz M; Carmona R; Pérez-Alvarez L; Cilla G; Suarez MD; Delgado E; Contreras G; Corral J; de Goicoetxea MJ; Medrano L; Lezaún MJ; Nájera R;
J Clin Virol; 2005 Jul; 33(3):224-9. PubMed ID: 15911444
[TBL] [Abstract][Full Text] [Related]
45. HIV drug resistance testing by high-multiplex "wide" sequencing on the MiSeq instrument.
Lapointe HR; Dong W; Lee GQ; Bangsberg DR; Martin JN; Mocello AR; Boum Y; Karakas A; Kirkby D; Poon AF; Harrigan PR; Brumme CJ
Antimicrob Agents Chemother; 2015 Nov; 59(11):6824-33. PubMed ID: 26282425
[TBL] [Abstract][Full Text] [Related]
46. Ultrasensitive single-genome sequencing: accurate, targeted, next generation sequencing of HIV-1 RNA.
Boltz VF; Rausch J; Shao W; Hattori J; Luke B; Maldarelli F; Mellors JW; Kearney MF; Coffin JM
Retrovirology; 2016 Dec; 13(1):87. PubMed ID: 27998286
[TBL] [Abstract][Full Text] [Related]
47. Minority variants associated with resistance to HIV-1 nonnucleoside reverse transcriptase inhibitors during primary infection.
Nicot F; Saliou A; Raymond S; Sauné K; Dubois M; Massip P; Marchou B; Delobel P; Izopet J
J Clin Virol; 2012 Oct; 55(2):107-13. PubMed ID: 22818969
[TBL] [Abstract][Full Text] [Related]
48. HIV-1 genotypic drug resistance testing: digging deep, reaching wide?
Van Laethem K; Theys K; Vandamme AM
Curr Opin Virol; 2015 Oct; 14():16-23. PubMed ID: 26114581
[TBL] [Abstract][Full Text] [Related]
49. Prospective Evaluation of the Vela Diagnostics Next-Generation Sequencing Platform for HIV-1 Genotypic Resistance Testing.
Weber J; Volkova I; Sahoo MK; Tzou PL; Shafer RW; Pinsky BA
J Mol Diagn; 2019 Nov; 21(6):961-970. PubMed ID: 31382033
[TBL] [Abstract][Full Text] [Related]
50. HIV-1 drug resistance genotyping quality assessment: results of the ENVA7 Genotyping Proficiency Programme.
Pandit A; Mackay WG; Steel C; van Loon AM; Schuurman R
J Clin Virol; 2008 Dec; 43(4):401-6. PubMed ID: 18977690
[TBL] [Abstract][Full Text] [Related]
51. Concordance between allele-specific PCR and ultra-deep pyrosequencing for the detection of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutations.
Hunt GM; Morris L; Moorthy A; Coovadia A; Abrams EJ; Strehlau R; Kuhn L; Persaud D
J Virol Methods; 2014 Oct; 207():182-7. PubMed ID: 25034127
[TBL] [Abstract][Full Text] [Related]
52. Implementation of Next-Generation Sequencing for Hepatitis B Virus Resistance Testing and Genotyping in a Clinical Microbiology Laboratory.
Lowe CF; Merrick L; Harrigan PR; Mazzulli T; Sherlock CH; Ritchie G
J Clin Microbiol; 2016 Jan; 54(1):127-33. PubMed ID: 26537448
[TBL] [Abstract][Full Text] [Related]
53. MinVar: A rapid and versatile tool for HIV-1 drug resistance genotyping by deep sequencing.
Huber M; Metzner KJ; Geissberger FD; Shah C; Leemann C; Klimkait T; Böni J; Trkola A; Zagordi O
J Virol Methods; 2017 Feb; 240():7-13. PubMed ID: 27867045
[TBL] [Abstract][Full Text] [Related]
54. Development and optimization of an internally controlled dried blood spot assay for surveillance of human immunodeficiency virus type-1 drug resistance.
Buckton AJ; Bissett SL; Myers RE; Beddows S; Edwards S; Cane PA; Pillay D
J Antimicrob Chemother; 2008 Dec; 62(6):1191-8. PubMed ID: 18927229
[TBL] [Abstract][Full Text] [Related]
55. [Comparison of three genotyping methods for the detection of HIV-1 resistance to antiretroviral drugs].
Suárez A; Picazo J; Alonso R; Bouza E; Delgado R; Rodríguez-Noriega A; Bernal A; García A
Rev Esp Quimioter; 2002 Mar; 15(1):43-48. PubMed ID: 12582436
[TBL] [Abstract][Full Text] [Related]
56. Comparative performance evaluation of the HIV-1 LiPA protease and reverse transcriptase resistance assay on clinical isolates.
Tsongalis GJ; Gleeson T; Rodina M; Anamani D; Ross J; Joanisse I; Tanimoto L; Ziermann R
J Clin Virol; 2005 Dec; 34(4):268-71. PubMed ID: 16286050
[TBL] [Abstract][Full Text] [Related]
57. Clinical and analytical relevance of NNRTIs minority mutations on viral failure in HIV-1 infected patients.
Mohamed S; Ravet S; Camus C; Khiri H; Olive D; Halfon P
J Med Virol; 2014 Mar; 86(3):394-403. PubMed ID: 24248806
[TBL] [Abstract][Full Text] [Related]
58. Routine drug resistance testing in HIV-1 proviral DNA, using an automated next- generation sequencing assay.
Alidjinou EK; Coulon P; Hallaert C; Robineau O; Meybeck A; Huleux T; Ajana F; Hober D; Bocket L
J Clin Virol; 2019 Dec; 121():104207. PubMed ID: 31707202
[TBL] [Abstract][Full Text] [Related]
59. Optimized protocol for detection of HIV-1 drug mutations in patients with low viral load.
Stelzl E; Troppan KT; Winkler M; Korn K; Kessler HH
J Virol Methods; 2010 Sep; 168(1-2):152-4. PubMed ID: 20471425
[TBL] [Abstract][Full Text] [Related]
60. Low-abundance drug-resistant viral variants in chronically HIV-infected, antiretroviral treatment-naive patients significantly impact treatment outcomes.
Simen BB; Simons JF; Hullsiek KH; Novak RM; Macarthur RD; Baxter JD; Huang C; Lubeski C; Turenchalk GS; Braverman MS; Desany B; Rothberg JM; Egholm M; Kozal MJ;
J Infect Dis; 2009 Mar; 199(5):693-701. PubMed ID: 19210162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
